2Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China (Yao M,Yao DF,Qiu LW,Wu W,Sai WL,Yang JL and Zhang HJ),Department of Oncology,Yancheng First People’s Hospital,Yancheng 224001,China (Bian YZ),Department of Oncology,Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China (Zhang CG).Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量：52
3Adams LA, Knuiman is a stronger predictor coBol consumption [ (7Ptl) : 1089-1093. MW, Divitini ML, et al. Body mass index of alanine aminotransamanase levels than alchol consumption[J]. J Gastroenterol Hepatol, 2008, 23.
4Lee DH, Ha MH, Christiani DC. Body weight, alcohol consump- tion and liver enzyme activity-a 4-year follow-up study [J]. Int J Epidemiol, 2001,30(4) :766-770.
5苏中华中国五地区普通人群饮酒和健康状况流行病学调查.长沙:中南大学,2004.
6Stickel F, Poeschl G, Sehuppan D, et al. Serum hyalumnate correlates with histological progression in alcoholic liver disease [J]. Eur J Gastroenterol Hepatol, 2003,15(9) :945-950.
7Lande RG, Marin B. Biomarker characteristics of alcohol use in the U.S. Army [J]. J Addict Dis, 2009,28(2) : 158-163.
8Lawson TL, Thorsen MK, Erickson SJ, et al. Periportal halo: a CT sign of liver disease. Abdom Imaging, 1993, 18: 42-46.
9Cassani F, Zoli M, Baffoni L, et al. Prevalence and significance of abdominal lymphadenopathy in patients with chronic liver disease:an ultrasound study. J Clin Gastroenterol, 1990, 12: 42-46.
10Soresi M, Carroccio A, Agate V, et al. Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C. Am J Gastroenterol, 1999, 94: 497-501.
